The DFS of HCC patients with RAB11B gene alteration tended to be lower than that of patients without gene alteration, but it showed a very slight trend toward significance ( p = 0.286; Figure 5 E).
← all excerpts
Bioinformatics Analysis and Validation of the Role of <i>Lnc-RAB11B-AS1</i> in the Development and Prognosis of Hepatocellular Carcinoma.
1
0.2860
0.2860